|
|
||||||||
SPECIAL EXHIBIT |
1 Departments of Radiological Sciences (D.C.)
2 Internal Medicine (M.P.)
3 Pathology (S.E.C.), University of California, Irvine Medical Center, 101 The City Drive, Orange, CA 92868-3298
Index Terms: Breast neoplasms, 00.3112 Drugs, effects, 00.64 Fibroadenoma, 00.3112
| HISTORY |
|---|
|
|
|---|
| FINDINGS |
|---|
|
|
|---|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Multiple giant fibroadenomas are rare; to our knowledge, only 22 cases have been reported (4). Multiple giant fibroadenomas occur mainly in adolescent black girls (47). These lesions commonly recur after excision or are replaced by newly arising lesions and may result in massive breast enlargement and deformity bilaterally, sometimes requiring mastectomy (3,5,7).
The giant fibroadenomas seen in adolescent girls tend to be of the juvenile type, with prominent stromal cellularity, ductal hyperplasia, and stromal collagenation (5,7,8). In our patient, the giant fibroadenomas were of the adult type and did not demonstrate these proliferative changes.
A total of 12 cases of multiple fibroadenomas in association with cyclosporin A therapy were described by Baildam et al (9) and Rolles and Calne (10). The size of the fibroadenomas was not specified, but most of the lesions were palpable. Unlike the present case, none of these 12 cases involved giant fibroadenomas. In the study by Baildam et al (9), fibroadenomas were seen in 13 of 29 women with renal transplants who had undergone cyclosporin A therapy. Ten cases involved multiple lesions, and in five cases, the lesions were bilateral. There were no abnormal breast findings in 10 women treated with steroids and azathioprine alone. In one of the two cases reported by Rolles and Calne (10), there was resolution of the masses after cessation of cyclosporin A therapy. In none of the reported cases was there an inexorable increase in lesion size necessitating mastectomy.
Various mechanisms for the association of cyclosporin A with multiple fibroadenomas have been suggested, including effect on fibroblasts (some fibroblasts have cyclosporin receptors), effect on hypothalamic-pituitary axis (demonstrated in rats), and, less likely, resolution of uremia (9).
Multiple giant fibroadenomas manifest as well-defined round, oval, or lobulated masses at mammography. At ultrasonography, well-defined, homogeneously hypoechoic solid masses embedded in a highly echogenic stroma (as seen in this case) have been reported (4,11). A single supplying vessel has been described at Doppler sonography (4). In one previously reported case, T1- and T2-weighted magnetic resonance (MR) imaging showed well-circumscribed, encapsulated masses with low signal intensity (4). Dynamic contrast materialenhanced MR imaging demonstrated rapid enhancement within 1 minute, so that malignancy could not be excluded.
Fibroadenomas and cysts may be indistinguishable at both physical examination and mammography. Once cysts are excluded with ultrasonography, the differential diagnosis of multiple large, circumscribed masses includes giant fibroadenomas, phyllodes tumors, and (particularly in immunosuppressed patients) lymphoma.
Mammographic differentiation of giant fibroadenomas from phyllodes tumors is not possible because all these lesions, benign or malignant, may manifest as smooth, sharply defined round or lobulated masses (12). At ultrasonography, the presence of clefts or cysts in a well-defined solid mass would favor the diagnosis of phyllodes tumor; however, this finding is not pathognomonic (12) and biopsy is mandatory.
The mean age of patients with fibroadenomas is 30 years; in contrast, that of patients with phyllodes tumors is about 45 years (1,2). However, phyllodes tumors may also occur in adolescent girls and young women. Furthermore, these lesions are usually unilateral, although they may be bilateral (5).
The presence of fibroadenomas is considered a slight risk factor for breast cancer (13). To our knowledge, no malignant degeneration has been reported in patients with multiple giant fibroadenomas. In contrast, phyllodes tumors may undergo malignant degeneration in a small percentage of cases (12).
In this case, results of ultrasound-assisted core needle biopsy helped confirm the diagnosis. The patient subsequently underwent bilateral subcutaneous mastectomy and reconstruction (Figs 3, 4).
|
|
| Footnotes |
|---|
From the 1998 RSNA scientific assembly.
Received for publication September 30, 1998. Revision received October 7, 1998. November 6, 1998. Accepted for publication November 6, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. P. Weinstein, S. G. Orel, L. Collazzo, E. F. Conant, T. J. Lawton, and B. Czerniecki Cyclosporin A-induced Fibroadenomas of the Breast: Report of Five Cases Radiology, August 1, 2001; 220(2): 465 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. T. Leung and E. A. Sickles Multiple Bilateral Masses Detected on Screening Mammography: Assessment of Need for Recall Imaging Am. J. Roentgenol., July 1, 2000; 175(1): 23 - 29. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |